MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
30.55
-0.89 (-2.83%)
At close: Mar 6, 2026, 4:00 PM EST
30.61
+0.06 (0.20%)
After-hours: Mar 6, 2026, 4:10 PM EST
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $1.44 billion as of March 6, 2026. Its market cap has increased by 264.39% in one year.
Market Cap
1.44B
Enterprise Value
1.05B
1-Year Change
264.39%
Ranking
Category
Stock Price
$30.55
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $1.44B, an increase of 182.65%. That is a compound annual growth rate of 102.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.44B | 1.72% |
| Dec 31, 2025 | 1.42B | 129.95% |
| Dec 31, 2024 | 615.88M | 20.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuvation Bio | 1.57B |
| Nurix Therapeutics | 1.57B |
| Kodiak Sciences | 1.56B |
| Sionna Therapeutics | 1.56B |
| Intellia Therapeutics | 1.55B |
| Biohaven | 1.55B |
| Ardelyx | 1.54B |
| Vir Biotechnology | 1.45B |